Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Ianalumab + Standard Therapy for Lupus Nephritis
Recruiting1 awardPhase 3
Fairfax, Virginia
This trial will compare how well two different doses of ianalumab work in combination with standard of care (SoC) to treat active lupus nephritis (LN), as well as how safe and tolerable the doses are.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.